The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour’s TMPRSS2-ERG Fusion Status
Objectives. To investigate the added value of assessing transcripts for the long cAMP phosphodiesterase-4D (PDE4D) isoforms, PDE4D5 and PDE4D9, regarding the prognostic power of the ‘CAPRA & PDE4D7’ combination risk model to predict longitudinal postsurgical biological outcomes in prostate cance...
Main Authors: | Dianne van Strijp, Christiane de Witz, Birthe Heitkötter, Sebastian Huss, Martin Bögemann, George S. Baillie, Miles D. Houslay, Chris Bangma, Axel Semjonow, Ralf Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2019/8107807 |
Similar Items
-
Overexpression of truncated ERG from TMPRSS2-ERG fusion and prostate cancer development
by: Melanie Leong, et al.
Published: (2009-09-01) -
5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer.
by: Francesca Zammarchi, et al.
Published: (2013-01-01) -
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
by: Scott A. Tomlins, et al.
Published: (2008-02-01) -
Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
by: Manuela Krumbholz, et al.
Published: (2019-01-01) -
Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2021-06-01)